Pfizer (PFE) announced that the U.S. FDA has approved the supplemental Biologics License Application for ADCETRIS in combination with lenalidomide ...
On Tuesday, the Buffalo community came together to spread awareness about sickle cell disease during Black History Month.
Kyle Registre's childhood dream of becoming a pilot can finally come true now that he says he's been cured of sickle cell ...
After moving from Sierra Leone to London, guest columnist Richard Bayliss received a proper diagnosis and care plan for his ...
There will be a blood drive for sickle cell disease this weekend in South Jersey to mark the beginning of Black History Month. Sickle cell disease is the most common inherited blood disorder.
Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps remain in advanced treatments for SCD. To help address this burden, Tanzania ...
The newest gene therapy treatment, Casgevy, treats sick cell disease and transfusion-dependent beta thalassemia. Its addition means that CHLA provides the most cell and gene therapy treatments for ...
FRIDAY, Jan. 24, 2025 (HealthDay News) -- People with sickle cell disease often struggle with memory, focus, learning and problem solving, setting them back in school and the workplace.
New data published today shows that 784 patients a day were in hospital with norovirus last week (week ending 19 January 2025), up from 650 the previous week. Levels ...
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating the safety ...
Carla Howard, a Hoxworth blood donor recruiter and sickle cell patient, was in attendance, sharing her story. "My mother found out I had sickle cell at 2 years old," she said. "She stated that I ...
However, carriers can have children who inherit sickle cell disease and may exhibit symptoms. Therefore, unless you conduct DNA paternity tests that confirm the child is not yours, the fact that ...